|
|
Volumn 22, Issue 6, 2007, Pages 409-418
|
|
Prediction of the metabolic interaction of nateglinide with other drugs based on in vitro studies.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
CYCLOHEXANE DERIVATIVE;
CYP2C9 PROTEIN, HUMAN;
CYP3A4 PROTEIN, HUMAN;
CYTOCHROME P450;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
NATEGLINIDE;
PHENYLALANINE;
UNCLASSIFIED DRUG;
UNSPECIFIC MONOOXYGENASE;
ARTICLE;
BIOLOGICAL MODEL;
BIOTRANSFORMATION;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG INTERACTION;
ENZYMOLOGY;
HUMAN;
IN VITRO STUDY;
KINETICS;
LIVER MICROSOME;
METABOLISM;
ARYL HYDROCARBON HYDROXYLASES;
BIOTRANSFORMATION;
CYCLOHEXANES;
CYTOCHROME P-450 ENZYME SYSTEM;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
ENZYME INHIBITORS;
HUMANS;
HYPOGLYCEMIC AGENTS;
KINETICS;
MICROSOMES, LIVER;
MODELS, BIOLOGICAL;
PHENYLALANINE;
|
|
EID: 38749150390
PISSN: 13474367
EISSN: None
Source Type: Journal
DOI: 10.2133/dmpk.22.409 Document Type: Article |
|
Times cited : (20)
|
|
References (0)
|
